These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38531528)
1. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review. Saranya I; Dharshini VS; Akshaya RL; Subhashini PS; Selvamurugan N Int J Biol Macromol; 2024 May; 266(Pt 2):131075. PubMed ID: 38531528 [TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
3. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes. Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017 [TBL] [Abstract][Full Text] [Related]
4. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes. Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038 [TBL] [Abstract][Full Text] [Related]
5. Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis. Liu J; Li H; Zheng B; Sun L; Yuan Y; Xing C Dig Dis Sci; 2019 Jul; 64(7):1868-1877. PubMed ID: 30734239 [TBL] [Abstract][Full Text] [Related]
6. ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies. Yang S; Wang X; Zhou X; Hou L; Wu J; Zhang W; Li H; Gao C; Sun C Biomed Pharmacother; 2023 Jun; 162():114698. PubMed ID: 37060661 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer. Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237 [TBL] [Abstract][Full Text] [Related]
8. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer. Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248 [TBL] [Abstract][Full Text] [Related]
9. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer. Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129 [TBL] [Abstract][Full Text] [Related]
10. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour. Tang F; Lu Z; Wang J; Li Z; Wu W; Duan H; He Z BMC Med Genomics; 2019 Dec; 12(1):194. PubMed ID: 31842887 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma. Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers. Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer. Tuersong T; Li L; Abulaiti Z; Feng S Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025 [TBL] [Abstract][Full Text] [Related]
14. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma. Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120 [TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network. Hu D; Zhang B; Yu M; Shi W; Zhang L Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035 [TBL] [Abstract][Full Text] [Related]
16. Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset. Wang X; Gao C; Feng F; Zhuang J; Liu L; Li H; Liu C; Wu J; Zheng X; Ding X; Sun C Biomed Res Int; 2020; 2020():4078596. PubMed ID: 32775417 [TBL] [Abstract][Full Text] [Related]
17. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC). Qattan A Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473871 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Breast Cancer Progression by Noncoding RNAs. Akshaya RL; Rohini M; Selvamurugan N Curr Cancer Drug Targets; 2020; 20(10):757-767. PubMed ID: 32652909 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer. Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058 [TBL] [Abstract][Full Text] [Related]
20. Identification of competitive endogenous RNAs network in breast cancer. Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]